🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to demonstrate, in 18-55 year old adults, the ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-09
Trial ID
NCT00453986
Treatments Being Tested
The purpose of this study is to demonstrate, in 11-17 year old subjects, th...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05-02
Trial ID
NCT00464815
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03
Trial ID
NCT00196963
Treatments Being Tested
The purpose of this study is to evaluate the safety, reactogenicity, immuno...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-09
Trial ID
NCT00196950
Treatments Being Tested
This study will investigate the long-term protection offered by GSK Biologi...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02
Trial ID
NCT00390143
Treatments Being Tested
The purpose of the observer-blinded study is to determine the immunogenicit...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-08-27
Trial ID
NCT01154088
This study has 2 phases, a vaccination phase and a long-term follow-up phas...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02-07
Trial ID
NCT00427908
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03-24
Trial ID
NCT00196976
Meningococcal disease is mostly caused by N. meningitidis of serogroups A, ...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-12-23
Trial ID
NCT00356369
Treatments Being Tested
The purpose of this study is to evaluate that the vaccine produced with the...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-06
Trial ID
NCT00227422
Treatments Being Tested